Bibliografia UJ CM

1/7
Jorge E. Cortes, Jane Apperley, Elza Lomaia, Beatriz Moiraghi, Maria Undurraga Sutton, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey Howard Lipton, Charles Schiffer, James K. McCloskey, Andreas Hochhaus, Philippe H. Rousselot, Gianantonio Rosti, Hugues de Lavallade, Michael J. Mauro, Tracey Hall, Vickie Lu, Shouryadeep Srivastava, Michael W. Deininger.
OPTIC primary analysis : a dose-optimization study of 3 starting doses of ponatinib (PON).
Journal of Clinical Oncology
2021 : Vol. 39, nr 15 suppl., abstr. 7000
2021 ASCO Annual Meeting I.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
SZZ
SIF
Adres url:
DOI:
2/7
Jorge Cortes, Jane F. Apperley, Elza Lomaia, Beatriz Moiraghi, Maria Soledad Undurraga, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, Charles A. Schiffer, James McCloskey, Andreas Hochhaus, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Anna Turkina, Christine Rojas, Christopher Arthur, Lori J. Maness, Moshe Talpaz, Michael J. Mauro, Tracey Hall, Vickie Lu, Shouryadeep Srivastava, Michael W. Deininger.
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia : a randomized, open-label phase 2 clinical trial.
Blood
2021 : Vol. 138, nr 21, s. 2042-2050
Auto korespondencyjny: Jorge Cortes.
p-ISSN: 0006-4971
e-ISSN: 1528-0020
AZ
ORG
AIF
IF: 25.669
Adres url:
Streszczenie w PubMed:
DOI:
3/7
Markus Pfirrmann, Richard E. Clark, Witold Prejzner, Michael Lauseker, Michele Baccarani, Susanne Saussele, François Guilhot, Sonja Heibl, Rüdiger Hehlmann, Edgar Faber, Anna Turkina, Gert Ossenkoppele, Martin Hoglund, Andrey Zaritskey, Boris Labar, Laimonas Griskevicius, Tomasz Sacha, Ulla Olsson-Strömberg, Daniela Zackova, Hele Everaus, Francisco Cervantes, Perttu Koskenvesa, Adriana Colita, Irena Zupan, Andrija Bogdanovic, Fausto Castagnetti, Joelle Guilhot, Joerg Hasford, Andreas Hochhaus, Verena S. Hoffmann.
The EUTOS long-term survival (ELTS) score is superior to the Sokalscore for predicting survival in chronic myeloid leukemia.
Leukemia
2020 : Vol. 34, nr 8, s. 2138-2149
Autor korespondencyjny: Markus Pfirrmann.
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 0887-6924
AZ
ORG
AIF
IF: 11.528
Adres url:
Streszczenie w PubMed:
4/7
Michael Lauseker, Katharina Bachl, Anna Turkina, Edgar Faber, Witold Prejzner, Ulla Olsson-Stromberg, Michele Baccarani, Elza Lomaia, Daniela Zackova, Gert Ossenkoppele Ossenkoppele, Laimonas Griskevicius, Gabriele Schubert-Fritschle, Tomasz Sacha, Sonja Heibl, Perttu Koskenvesa, Andrija Bogdanovic, Richard E. Clark, Joelle Guilhot, Verena S. Hoffmann, Joerg Hasford, Andreas Hochhaus, Markus Pfirrmann.
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin.
American Journal of Hematology
2019 : Vol. 94, nr 11, s. 1236-1243, il., bibliogr. 34 poz., abstr.
Autor korespondencyjny: Michael Lauseker.
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 0361-8609
AZ
ORG
AIF
IF: 6.973
Adres url:
Streszczenie w PubMed:
5/7
Thomas Ernst, Feng Lin, Helen E. White, Paul La Rosee, Thomas Lion, Gerlinde Mitterbauer-Hohendann, Peter Vandenberghe, Renata Zadro, Katerina Machova Polakova, Radek Plachy, Charlotte Guldborg Nyvold, Tuija Lundan, Jean-Michel Cayuela, Thoralf Lange, Martin C. Muller, Katerina Zoi, Hajnalka Andrikovics, Tali Tohami, Fabrizio Pane, Simona Soverini, Francesca Arruga, Lene Eggen, Tomasz Sacha, Joana Diamond, Rodica Talmaci, Tadej Pajic, Dolors Colomer, Monica Hermanson, Elisabeth Oppliger Leibundgut, Peter J.M. Valk, Ugur Ozbek, Gareth Gerrard, Giuseppe Saglio, Andreas Hochhaus, Nicholas C.P. Cross.
Harmonized testing for BCR-ABL kinase domain mutations in CML : results of a survey and first control round within 28 national reference laboratories in Europe.
Blood
2010 : Vol. 116, nr 21, abstr. 894
52nd ASH Annual Meeting, Orlando, FL, December 4-7, 2010.
SZZ
SIF
6/7
Martin C. Muller, Umang Munjal, Philipp Erben, Thomas Lion, Gerlinde Mitterbauer-Hohendann, Hakim El Housni, Nancy Boeckx, Renata Zadro, Jiri Mayer, Peter Rohon, Jana Rulcova, Lykke Grubach, Kadri Raudsepp, Veli Kairisto, Francois-Xavier Mahon, Claude Preudhomme, Sandrine Hayette, Jean Gabert, Jean-Michel Cayuela, Christian Thiede, Lars Galonska, Heike Pfeifer, Carsten Hirt, Philippe Schafhausen, Nils von Neuhoff, Martin Roskos, Christiane Pott, Thoralf Lange, Georg Hess, Susanne Schnittger, Annika Dufour, Steffen Koschmieder, Frank Stegelmann, Katerina Zoi, Kostas Stamatopoulos, Hajnalka Andrikovics, Tali Tohami, Giovanni Martinelli, Barbara Izzo, Enrico Gottardi, Mindaugas Stoskus, Dag Andre Nymoen, Tomasz Sacha, Joana Diamond, Rodica Talmaci, Andrey Misyurin, Michael V. Dubina, Tadej Pajic, Josep F. Nomdedeu, Dolors Colomer, Gisela Barbany-Bustinza, Hans Ehrencrona, Elisabeth Oppliger Leibundgut, Jeroen Janssen, Vincent H.J. Van der elden, Peter J.M. Valk, Ugur Ozbek, Lihui Wang, Gareth Gerrard, Helen E. White, Thomas Schenk, Thomas Ernst, Rudiger Hehlmann, Giuseppe Saglio, Andreas Hochhaus, Nicholas C.P. Cross.
Stability of conversion factors for BCR-ABL monitoring - implications for the frequency of validation rounds.
Blood
2010 : Vol. 116, nr 21, abstr. 893
52nd ASH Annual Meeting, Orlando, FL, December 4-7, 2010.
SZZ
SIF
7/7
Tomasz Sacha, Andreas Hochhaus, Benjamin Hanfstein, Martin C. Müller, Zbigniew Rudzki, Jacek Czopek, Teresa Wolska-Smoleń, Sylwia Czekalska, Zoriana Salamanchuk, Małgorzata Jakóbczyk, Aleksander B. Skotnicki.
ABL-kinase domain point mutation as a cause of imatinib (STI571) resistance in CML patient who progress to myeloid blast crisis.
Leukemia Research
2003 : Vol. 27, nr 12, s. 1163-1166, il., bibliogr. 8 poz., abstr.
AZ
KAZ
AIF
IF: 2.333
Adres url:
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ